Pfizer 2013 Annual Report Download - page 122

Download and view the complete annual report

Please find page 122 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Financial Summary
Pfizer Inc. and Subsidiary Companies
2013 Financial Report
121
Year Ended/As of December 31,(a)
(MILLIONS, EXCEPT PER COMMON SHARE DATA) 2013 2012 2011 2010 2009
Revenues(b) $51,584 $54,657 $61,035 $61,591 $46,314
Income from continuing operations(b) 11,410 9,021 7,860 7,951 8,361
Total assets 172,101 185,798 188,002 195,014 212,949
Long-term obligations(b), (c) 72,115 74,934 75,914 76,789 83,762
Earnings per common share—basic
Income from continuing operations attributable to Pfizer Inc. common
shareholders $1.67 $1.21 $1.00 $0.99 $1.19
Discontinued operations—net of tax(d) 1.56 0.75 0.28 0.04 0.04
Net income attributable to Pfizer Inc. common shareholders $3.23 $1.96 $1.28 $1.03 $1.23
Earnings per common share—diluted
Income from continuing operations attributable to Pfizer Inc. common
shareholders $1.65 $1.20 $0.99 $0.98 $1.19
Discontinued operations—net of tax(d) 1.54 0.74 0.28 0.04 0.04
Net income attributable to Pfizer Inc. common shareholders $3.19 $1.94 $1.27 $1.02 $1.23
Cash dividends declared per common share $0.96 $0.88 $0.80 $0.72 $0.80
(a) Reflects the acquisition of King on January 31, 2011 and Wyeth on October 15, 2009.
(b) All amounts reflect the June 24, 2013 disposition of Zoetis and its presentation as a discontinued operation in all periods presented.
(c) Defined as Long-term debt, Pension benefit obligations, net, Postretirement benefit obligations, net, Noncurrent deferred tax liabilities, Other taxes payable and
Other noncurrent liabilities.
(d) Includes (i) the Animal Health (Zoetis) business through June 24, 2013, the date of disposal, (ii) the Nutrition business through November 30, 2012, the date of
disposal and (iii) the Capsugel business through August 1, 2011, the date of disposal.